EPHA3 and acute myeloid leukemia: There was no difference between NHD13-EphA3−/− mice and NHD13- EphA3+/+ mice in the incidence of AML in this cohort (Supplementary Figure S2), and AML events were censored from the T-ALL-free survival curve.